0001213900-19-026153.txt : 20191213
0001213900-19-026153.hdr.sgml : 20191213
20191213163105
ACCESSION NUMBER: 0001213900-19-026153
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191212
FILED AS OF DATE: 20191213
DATE AS OF CHANGE: 20191213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHABER CHRISTOPHER J
CENTRAL INDEX KEY: 0001068029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 191284945
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER NAME:
FORMER CONFORMED NAME: SCHABER CHRISTOPHER
DATE OF NAME CHANGE: 19980811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2019-12-12
0
0000812796
SOLIGENIX, INC.
SNGX
0001068029
SCHABER CHRISTOPHER J
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
1
1
0
0
Chairman, CEO and President
Option (Right to Buy)
1.24
2019-12-12
4
A
0
60000
0
A
2019-12-12
2029-12-11
Common Stock
60000
60000
D
The stock option vested immediately as to 15,000 shares and vests as to the remainder at a rate of 3,750 of the shares on each three (3) month anniversary of December 12, 2019.
/s/ Christopher J. Schaber
2019-12-13